ProfileGDS4516 / 230110_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 56% 70% 71% 58% 63% 84% 90% 75% 56% 82% 89% 76% 79% 79% 82% 60% 58% 74% 83% 82% 66% 88% 86% 83% 75% 85% 58% 80% 64% 60% 76% 93% 56% 87% 61% 69% 80% 68% 68% 90% 82% 63% 73% 83% 54% 83% 85% 93% 91% 53% 86% 88% 94% 74% 87% 87% 84% 90% 79% 65% 84% 92% 60% 89% 56% 83% 61% 93% 81% 54% 57% 87% 74% 57% 85% 50% 77% 93% 79% 87% 94% 87% 77% 87% 68% 91% 93% 66% 90% 84% 91% 80% 69% 50% 72% 61% 87% 88% 80% 86% 82% 70% 86% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]5.8516156
GSM537345patient 119, cancer, LCM [OPG study]6.8609470
GSM537355patient 138, cancer, LCM [OPG study]6.9632771
GSM537366patient 154, cancer, LCM [OPG study]5.9329558
GSM537370patient 022, cancer, LCM [OPG study]6.2906763
GSM537380patient 037, cancer, LCM [OPG study]8.4652684
GSM537392patient 077, cancer, LCM [OPG study]9.4782990
GSM537415patient 032, cancer, LCM [OPG study]7.476675
GSM537417patient 042, cancer, LCM [OPG study]5.9061956
GSM537422patient 059, cancer, LCM [OPG study]8.0484682
GSM537423patient 064, cancer, LCM [OPG study]9.2436189
GSM537427patient 084, cancer, LCM [OPG study]7.5991376
GSM537430patient 090, cancer, LCM [OPG study]7.7133579
GSM537336patient 107, cancer, LCM [OPG study]7.8959479
GSM537337patient 108, cancer, LCM [OPG study]8.3026782
GSM537348patient 124, cancer, LCM [OPG study]6.104660
GSM537349patient 125, cancer, LCM [OPG study]5.9333158
GSM537356patient 139, cancer, LCM [OPG study]7.1691374
GSM537361patient 147, cancer, LCM [OPG study]8.2499483
GSM537374patient 026, cancer, LCM [OPG study]7.9358282
GSM537377patient 033, cancer, LCM [OPG study]6.5066466
GSM537378patient 034, cancer, LCM [OPG study]9.0329988
GSM537379patient 036, cancer, LCM [OPG study]8.6410586
GSM537383patient 046, cancer, LCM [OPG study]8.3897283
GSM537388patient 063, cancer, LCM [OPG study]7.4238175
GSM537395patient 082, cancer, LCM [OPG study]8.7451485
GSM537400patient 099, cancer, LCM [OPG study]5.9462858
GSM537404patient 129, cancer, LCM [OPG study]7.7209580
GSM537409patient 141, cancer, LCM [OPG study]6.3908364
GSM537418patient 044, cancer, LCM [OPG study]6.0767860
GSM537425patient 070, cancer, LCM [OPG study]7.3586976
GSM537333patient 102, cancer, LCM [OPG study]9.9324893
GSM537342patient 116, cancer, LCM [OPG study]5.7953656
GSM537347patient 123, cancer, LCM [OPG study]8.7408587
GSM537350patient 127, cancer, LCM [OPG study]6.1661961
GSM537362patient 148, cancer, LCM [OPG study]6.7241169
GSM537363patient 150, cancer, LCM [OPG study]7.9355280
GSM537368patient 156, cancer, LCM [OPG study]6.7057568
GSM537376patient 031, cancer, LCM [OPG study]6.7287768
GSM537381patient 038, cancer, LCM [OPG study]9.3378990
GSM537386patient 057, cancer, LCM [OPG study]8.0477282
GSM537398patient 094, cancer, LCM [OPG study]6.2566863
GSM537402patient 109, cancer, LCM [OPG study]7.2090273
GSM537405patient 130, cancer, LCM [OPG study]8.1558183
GSM537371patient 023, cancer, LCM [OPG study]5.6550154
GSM537421patient 055, cancer, LCM [OPG study]8.3634183
GSM537424patient 065, cancer, LCM [OPG study]8.5705885
GSM537432patient 097, cancer, LCM [OPG study]9.877993
GSM537331patient 100, cancer, LCM [OPG study]9.5286391
GSM537332patient 101, cancer, LCM [OPG study]5.5630453
GSM537334patient 103, cancer, LCM [OPG study]8.6377486
GSM537338patient 110, cancer, LCM [OPG study]8.9169188
GSM537353patient 135, cancer, LCM [OPG study]10.198494
GSM537357patient 142, cancer, LCM [OPG study]7.3417974
GSM537358patient 143, cancer, LCM [OPG study]8.8559487
GSM537375patient 030, cancer, LCM [OPG study]8.7942387
GSM537389patient 068, cancer, LCM [OPG study]8.6109684
GSM537390patient 072, cancer, LCM [OPG study]9.534790
GSM537393patient 078, cancer, LCM [OPG study]7.8660879
GSM537399patient 095, cancer, LCM [OPG study]6.4160365
GSM537407patient 133, cancer, LCM [OPG study]8.2358884
GSM537408patient 140, cancer, LCM [OPG study]9.7794792
GSM537428patient 086, cancer, LCM [OPG study]6.1196760
GSM537354patient 136, cancer, LCM [OPG study]9.282389
GSM537410patient 146, cancer, LCM [OPG study]5.7926256
GSM537413patient 027, cancer, LCM [OPG study]8.544783
GSM537396patient 083, cancer, LCM [OPG study]6.1757861
GSM537397patient 088, cancer, LCM [OPG study]10.04493
GSM537330patient 006, cancer, LCM [OPG study]8.074681
GSM537369patient 015, cancer, LCM [OPG study]5.6289454
GSM537373patient 025, cancer, LCM [OPG study]5.856557
GSM537401patient 106, cancer, LCM [OPG study]8.8620887
GSM537343patient 117, cancer, LCM [OPG study]7.231274
GSM537367patient 155, cancer, LCM [OPG study]5.8931757
GSM537382patient 041, cancer, LCM [OPG study]8.5693185
GSM537385patient 053, cancer, LCM [OPG study]5.4210150
GSM537391patient 073, cancer, LCM [OPG study]7.5855477
GSM537419patient 045, cancer, LCM [OPG study]9.6689293
GSM537420patient 052, cancer, LCM [OPG study]7.7190779
GSM537429patient 089, cancer, LCM [OPG study]8.9840187
GSM537431patient 096, cancer, LCM [OPG study]9.8658194
GSM537387patient 061, cancer, LCM [OPG study]8.9346387
GSM537414patient 028, cancer, LCM [OPG study]7.6990977
GSM537433patient 098, cancer, LCM [OPG study]8.8614387
GSM537335patient 104, cancer, LCM [OPG study]6.7265568
GSM537339patient 111, cancer, LCM [OPG study]9.7776291
GSM537340patient 113, cancer, LCM [OPG study]9.9568893
GSM537344patient 118, cancer, LCM [OPG study]6.5043166
GSM537346patient 011, cancer, LCM [OPG study]9.4526890
GSM537351patient 128, cancer, LCM [OPG study]8.4521684
GSM537352patient 134, cancer, LCM [OPG study]9.5594791
GSM537359patient 144, cancer, LCM [OPG study]7.8035380
GSM537360patient 145, cancer, LCM [OPG study]6.8552169
GSM537364patient 152, cancer, LCM [OPG study]5.3812250
GSM537365patient 153, cancer, LCM [OPG study]7.0398972
GSM537372patient 024, cancer, LCM [OPG study]6.1446661
GSM537384patient 048, cancer, LCM [OPG study]8.7706987
GSM537394patient 081, cancer, LCM [OPG study]9.06488
GSM537403patient 121, cancer, LCM [OPG study]7.9254980
GSM537406patient 131, cancer, LCM [OPG study]8.5858486
GSM537411patient 149, cancer, LCM [OPG study]8.0958482
GSM537412patient 019, cancer, LCM [OPG study]6.8820470
GSM537416patient 035, cancer, LCM [OPG study]8.8564386
GSM537426patient 079, cancer, LCM [OPG study]8.0480580